The article you quoted was published on 26 April 2017 and mentioned "The Data Safety Monitor Board meeting will be held in the beginning of May [...]".
On 9 May 2017 the company released the following:
"International Stem Cell Corporation Receives Approval to Start Second Patient Cohort in Clinical Trial for Parkinson’s Disease"
https://globenewswire.com/news-rele...n-Clinical-Trial-for-Parkinson-s-Disease.html
First Cohort Enrollment Completed in CYP-001 Clinical Trial; Reiterate Buy, page-34
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.0¢ | $13.43K | 65.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 109917 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 9225 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |